NCT07790276Not yet recruiting
Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis
Glycemic Assessment Based on Continuous Glucose Monitoring and Clinical Outcomes in People With Diabetes on Peritoneal Dialysis: a Multi-centered Prospective Study
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
This prospective, multicenter observational study will evaluate glucose profiles using continuous glucose monitoring (CGM) in 100 adults with diabetes receiving peritoneal dialysis (PD) or planning to start PD within 3 months. The study will examine associations between CGM metrics and PD regimen, glucose-lowering treatment, conventional glycemic markers, dialysis-related measures, and clinical outcomes including glycemic emergencies, hospitalizations, cardiovascular events, and mortality over 12 months.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 21 Aug 2026
- Start date
- Aug 2026
- Primary completion date
- Jun 2028
- Lead sponsor
- Elaine Chow
- Diseases
- Chronic kidney disease
- NCT number
- NCT07790276
What you commit to
- Study type: Observational
- Planned participants: 100
- From Aug 2026 to the primary completion date, Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are planning to switch to hemodialysis or renal transplant in the coming 3 months
- Current use or recent exposure to any medication that in the opinion of the investigator could have an influence on the patient's ability to participate in this study or on the performance of the test device.
Other illness
- Extensive skin changes/diseases that preclude wearing the required number of devices on normal skin at the proposed application sites
- Any active acute or chronic disease or condition that, in the opinion of the investigator, might interfere with the performance of this study.
- Any active acute or chronic infectious disease that, in the opinion of the investigator, would pose an excessive risk to study staff.
- Have a known allergy to medical-grade adhesives or known hypersensitivity to any of the products used in the study.
Lab values
- HbA1c \> 11% at enrolment
Other
- Life expectancy \<6 months
- Currently pregnant, as demonstrated by a positive pregnancy test at screening for women of reproductive potential.
- Have MRI scan, CT scan, or diathermy scheduled during the proposed period of sensor wearing during the study
Who the study is looking for
- Stage 5 CKD patients
- who have received PD for at least 3 months, OR
- who are planned for PD within the next 3 months.
- Age 18-80 years old
- Known history of type 1 or type 2 diabetes for at least 3 months
- Women who are not pregnant, lactating or planning a pregnancy during their participation in the clinical study.
- Willingness, ability and commitment to comply with the testing, procedure and follow-up outlined in this protocol including (but not limited to) frequency of clinic visits and use of pre-specified glucose monitoring devices.
- Willingness to abstain from swimming during their participation in the measurement phase.
- In the opinion of the investigator, absence of any physical limitations, addictive diseases, or underlying medical conditions (including mental health) that may preclude the patient from being a good study candidate.
- Written informed consent to participate in the study provided by the patient.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Medicine and Therapeutics, The Chinese University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.